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Abstract 
Natural products and natural product derivatives comprise some of the most successful 
drugs to date. Many natural products derive from the secondary metabolite profiles of high GC 
content actinomycete bacteria of the genus Streptomyces, which are sometimes associated with 
eukaryotic hosts. Identification of biosynthetic gene sequences for natural product secondary 
metabolites in Streptomyces can assist in isolation of the identified natural product. Moreover, the 
biosynthetic pathways of drug-like secondary metabolites derived from Streptomyces bacteria 
often provide insight into the available metabolites that can be produced. As a result, identification 
of bacteria capable of producing antibacterial products, including Streptomyces, can often lead to 
identification of biologically relevant secondary metabolites.  
It has been hypothesized that symbiotic relationships between invertebrate hosts and 
bacteria have evolved to protect host organisms from pathogenic invasion. Many invertebrates 
contain only an innate immune system incapable of adaptation, suggesting one hypothesis that this 
primitive immunity may be supplemented through the presence of symbiotic bacteria. To identify 
immune system augmenting methods, recent research has identified new techniques that 
investigate adaptive immune system enhancement through protein kinase C (PKC) activation and 
calcium channel influx in addition to suppression.  
The research described here investigated a novel strain of antibiotic-producing 
Streptomyces, isolated from the invasive tunicate Styela clava collected from the University of 
Connecticut at Avery Point (Groton, CT). During the investigation of the secondary metabolite 
production, tumor promoting and PKC activating metabolite teleocidin A-1 was identified via a 
novel assay screen. The assay screen was designed to investigate small molecules that can enhance 
lytic granule exocytosis from cytotoxic T-lymphocytes either by stimulating calcium influx or 
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activation of PKC. Identification of teleocidin A-1 inspired further investigation as to whether the 
bacterial secondary metabolite is developed to influence specific pathways of the host tunicate 
immune system. This hypothesis was investigated through attempts to localize the bacteria 
producing teleocidin A-1 to specific areas within the tunicate, including the gut and outer tunic. It 
was hypothesized that bacterial localization in or around various organs would lead to influence 
by secondary metabolites produced by bacteria, including teleocidin A-1. Thus, localization of 
bacteria by the host may indicate an influence by secondary metabolites on various organs and 
organ systems. Whole genome sequencing was employed to identify biosynthetic gene clusters 
that might play a role in antibiotic natural product biosynthesis as well as biosynthesis of teleocidin. 
After sequencing the bacterial genome, DNA samples isolated from various tunicate tissues were 
examined for bacterial DNA involved in the biosynthesis of teleocidin and for the presence of 
other antibiotic-producing Streptomyces bacteria. Results from localization experiments indicate 
that bacteria associated with antibiotic and natural product production are localized within the 
tunicate body, but not within the outer tunic membrane. 
 
Keywords: teleocidin, Streptomyces, Styela clava, bacteria, tunicate, secondary metabolites, 
natural products
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I. Introduction 
Marine invertebrates and their associated microorganisms can produce ecologically and 
physiologically relevant bioactive secondary metabolites (Kobayashi and Ishibashi, 1993). In 
particular, organisms from the phylum Urochordata are responsible for the production of novel 
metabolites such as cephalostatin, derived from the hemichordate marine tube worm, 
Cephalodiscus gilchristi, mandelalides isolated from the marine ascidian Lissoclinum sp., and 
methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase-inhibiting bisindole 
alkaloids derived from the marine sponge, Topsentia pachastrelloides (Davies-Coleman and Veale, 
2015). Natural products isolated from tunicates have a history of success as anti-cancer drugs or 
drug leads including didemnin B, plitidepsin, and ecteinascidin 743 (Figure 1) (Rinehart, 2000). 
Didemnin B was isolated from tunicates located in the Caribbean, while ptlitidepsin and 
ecteinascidin 743 were isolated from the tunicates Aplidium albicans and Ecteinascidia turbinata, 
respectively. Late phase clinical trial research for the treatment of leukemia, melanoma, ovarian 
cancer, breast, prostrate, and gastric tumors as well as non-small cell lung tumors was examined 
with didemnin B and plitidepsin (Sakai, et al., 1996). Similarly, ecteinascidin 743 has been 
approved for treatment of soft-tissue sarcoma and is in clinical trials for the treatment of breast, 
melanoma, non-small cell lung, and ovarian cancers (Sakai, et al., 1996).  
The previously mentioned drug candidates represent a portion of the large number of 
natural products isolated directly from tunicates. Many of the natural products isolated from 
tunicates contain peptidic, polyketide, alkaloid, and terpenoid structural motifs, which resemble 
structural compounds derived from symbiotic and associated bacteria (Schmidt and Donia, 2010). 
Indeed, it has been suggested that the true source for ascidian secondary metabolite natural 
products derives from bacteria (Ireland and Scheuer, 1980). In addition to tunicates there   
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Figure 1. Drug candidates derived from tunicates. Structures of didemnin B and plitidepsin (left), 
and ecteinascidin 743 (right) all isolated from tunicates (Rinehart, 2000). All three have entered 
late stage clinical trials for treatments of select cancers. Ecteinascidin 743 has been approved for 
the treatment of soft-tissue sarcomas, while the didemnins are still investigated in clinical trials. 
  
 
  
Didemnin B: R=OH 
Plitidepsin: R=O 
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have been several biologically relevant natural products associated with bacteria that are isolated 
from other marine invertebrates (Lopanik, 2014). In fact, bacteria associated with marine 
invertebrates have been implicated in the production of some of the more potent chemical defense 
mechanisms including the production of 2,3-indolinedione (isatin) (Gil-Turnes, et. al., 1989). 
Isatin has been utilized as a antifungal metabolite and identified in the chemical defense of the 
estuarine shrimp Palaemon macrodactylus against pathogenic fungi, namely Lagenidium 
callinectes.  Octalactin A was also isolated from marine Streptomyces and exhibited strong 
cytotoxic activity towards human colon cancer (Tapiolas, et al., 1991). Other cytotoxic compounds 
isolated from marine bacteria include alteramide A, isolated from a bacterium of the genus 
Alteromonas, derived from the Japanese sponge Halichondria okadai (Shigemori, et al., 1992). 
While several successful chemical defense secondary metabolites have been identified 
from marine host-associated bacteria, a review by Lopanik (2014) highlighted that identification 
of chemical defense symbiosis is accompanied by a number of challenges. For example, they 
suggest that in order to illustrate definitive chemical defense symbioses, sophisticated techniques 
for structure elucidation and symbiont localization are necessary such as chromatography and mass 
spectrometry. In addition, Lopanik (2014) indicates that it is necessary to demonstrate reproductive 
and defense system failure as a result of removing the symbiotic bacteria in order to reveal the 
bacterial role in preserving the health and survival of the host. Curing the host from its natural 
product-producing symbiont without removal of other associated microbes may be difficult if the 
relationship between the organisms is obligate. Moreover, if the bacteria responsible for producing 
the biological natural product is unculturable, reintroduction into the host-symbiont system may 
be unattainable. In addition, Moran, et al. (2008) suggested that the removal of a microbial 
symbiont followed by reintroduction into the environment may lead to genomic deterioration. The 
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review by Lopanik (2014) discussed that bioactive natural products produced by symbiotic 
microorganisms contribute to the chemical defense mechanisms used by invertebrate hosts despite 
the challenges associated with demonstrating a natural product defensive symbiosis. Finally, 
removal of the symbionts responsible for the chemical defenses can often lead to decreased growth 
rates and lowered viability amongst host invertebrates (Lopanik, 2014).  
 Protection and immunity for select marine invertebrates has evolved to include symbiotic 
microorganisms and their natural products. Marine invertebrates that possess an innate immune 
system have evolved a variety of complex mechanisms to compensate for their lack of a true 
adaptive immune system (Rowley and Powell, 2007). Examples of these mechanisms include 
utilizing symbiotic bacteria as external defense against disease and pathogens (Kobayashi and 
Ishibashi, 1993). While tunicates lack an adaptive system that is capable of acquiring immunity, 
tunicates do possess an innate immune system which includes a highly polymorphic 
allorecognition response system used to recognize individuals of the same species and maintain 
species homogeneity (De Tomaso, 2009). Previous research by De Tomaso (2009) asserts that the 
allorecognition responses to external stimuli serve as the evolutionary origin for intracellular 
polymorphic recognition strategies present in vertebrate adaptive immune systems. The colonial 
tunicate Botryllus schlosseri has been extensively studied for its allorecognition response (Taketa, 
et al., 2015). This colonial tunicate is characterized by a group of individual, asexually derived, 
genetically identical zooids that are connected by a central vascular network (Figure 2) (Manni, et 
al., 2007). While previous research has examined the availability of bacteria within colonial 
tunicates (Dishaw, et al., 2014), less research has been performed examining the presence of 
associated bacteria amongst solitary tunicates. Zooids that comprise colonial tunicates have 
adopted sophisticated methods of allorecognition to recognize colony members have been 
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extensively researched for colonial tunicates (Dishaw, et al., 2014). The edges of the colony 
contain the allorecognition site characterized by small protrusions known as ampullae (De Tomaso, 
2009). Previous research performed by Scofield, et al. (1982) identified that as colonies grow and 
come into contact with one another, the need for self-recognition systems becomes necessary. De 
Tomaso (2009) described that functional allorecognition responses will recognize genetically 
identical individuals and merge vasculature. Moreover, non-functional responses will reject the 
nearby ampullae and mount an inflammatory immune response. De Tomaso (2009) also 
demonstrated that allorecognition for tunicate colonies of Botryllus schlosseri is controlled by the 
fusion/histocompatibility (fuhc) gene locus. Individuals sharing one or two of the same alleles on 
this locus will merge together, while those with none will be rejected. Tunicates with incompatible 
alleles at the fuhc locus will undergo an inflammatory response resulting in a melanin scar at the 
site of interaction, which parallels natural killer cell mechanisms that destroy target cells if no self-
markers are present (Long, et al., 2013). In solitary tunicates, it has been proposed that similar 
histocompatibility reactivity governs the ability to recognize individuals with similar alleles 
despite differences in mating potential (Fuke and Numakunai, 1982). 
Several characteristics of the tunicate immune system are phylogenetically related to 
homologous aspects of mammalian immune systems. In particular, research by Vizzini, et al. 
(2015) has suggested that regulation of inflammation via cytokine IL-17 in solitary tunicate species 
shares a close relationship to mammalian cytokines, and thus likely shares a common chordate 
immune system ancestor. Specifically, IL-17 cytokine production is implied in the clearance of 
extracellular bacteria. Given that symbiotic bacteria may be providing chemical defense for their 
invertebrate hosts, ability to distinguish helpful versus harmful microorganisms becomes 
significant in the defense system for the host tunicate. Furthermore, ability to modulate immune   
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Figure 2. Colonial tunicate oozooids. Asexual reproduction of Botryllus schlosseri allows for 
identical zooid growth from the adult tunicate individual. All buds are connected by a central 
vascular network (Manni, et al., 2007). Recognition of unidentical tissue not produced by asexual 
budding allows for defense against pathogenic invasion. Figure modified from Gasparini, et. al. 
(2014). 
 
  
7 
 
system function becomes even more significant considering that associated bacteria may be 
responsible for secondary metabolites that influence immune system function and can contribute 
to defense against pathogen invasion. Bacteria that are responsible for natural product production 
involved in chemical defense of the host organism, thus, may not be cleared via immune system 
processes and may be involved in the production of immune system modifying secondary 
metabolites such as griseusrazin A which is derived from Streptomyces griseus (Lee, et al., 2016). 
Moreover, Erwin, et al. (2013) demonstrated that invasive tunicate species have a high degree of 
bacterial diversity and that the presence of a diverse population of associated bacteria allows for 
effective acclimation upon colonization for solitary invasive species. 
The high degree of diversity associated with tunicate associated bacteria results in a diverse 
set of biologically active natural products. In particular, marine associated actinobacteria have been 
implicated in the production of potent toxic natural product alkaloids that can result in human 
disease and pose a toxicological threat to native wildlife. For example, teleocidin A-1 (1) (Figure 
3) is an indolactam-V based secondary metabolite originally isolated from a marine Streptomyces 
bacteria known for toxicity to Japanese killifish (Takashima and Sakai, 1960). Research by Wang, 
et al. (1999) has shown 1 to be a potent tumor promoter and activator of protein kinase C (PKC). 
Specifically, Wang, et al. (1999) demonstrated that the indolactam-V scaffold from which 1 is 
based has been demonstrated to bind the C1B domain of PKC during activation similar to phorbol 
myrsitate acetate (PMA). In addition, stimulation of killer T-cells as part of immune responses 
occurs by two mechanisms: calcium influx and activation of PKC and ERK pathways (Pores-
Fernando and Zweifach, 2009). Two specific conformations of the indolactam-V scaffold have 
been identified for the binding events within the C1B binding domain of PKC (Wang, et al., 1999). 
These conformations are known as cis-twist and trans-sofa. While both conformations exist in 
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solution, the cis-twist conformation has been demonstrated as the conformation responsible for 
PKC activation (Wang, et al., 1999). Enantiomeric derivatives of 1 have been demonstrated to have 
over one hundred times weaker binding affinity than 1, and structural derivatives of 1 have been 
identified as tumor promoters, though with less activity as compared to 1 as a result of 
stereospecificity during binding (Jiang, et al., 2014).  
In 1979, 1 was isolated again from a marine cyanobacterium Moorea producens (formerly 
Lyngbya majuscula) and named lyngbyatoxin A (Cardellina II, et. al. 1979). The biosynthesis 
scheme for lyngbyatoxin A was first characterized from the marine cyanobacteria Moorea 
producens prior to the identification of teleocidin biosynthetic pathways (Figure 4) (Edwards and 
Gerwick, 2004). The proposed biosynthesis for lyngbyatoxin A incudes a modified NRPS/PKS 
pathway with four relevant genes that code for one dimodular nonribosomal peptide synthetase, a 
unique prenyltransferase, an MbtH-Cytochrome P-450 monooxygenase, and one 
reductase/oxidase enzyme . It was suggested that the involvement of the reductase/oxidase enzyme 
was used in the conversion from lyngbyatoxin A to derivatives lyngbyatoxin B and C (Figure 4) 
(Edwards and Gerwick, 2004). Because structural and enantiomeric derivatives were shown to be 
less potent PKC activators and tumor promoters than 1, it has been suggested that the biosynthesis 
of teleocidin and lyngbyatoxin derivatives may be used to regulate the relative toxicity of the local 
environment during secretion (Jiang, et al., 2014). More recently, Awakawa et al. (2014) identified 
gene homologs in teleocidin producing Streptomyces strains with the same catalytic domain 
structures as the lyngbyatoxin biosynthesis scheme published by Edwards and Gerwick (2004). In 
essence, homologs for the protein catalytic domains involved in the biosynthesis of lyngbyatoxin 
A were identified in the genome of teleocidin producing Streptomyces and designated as the 
teleocidin-producing biosynthetic gene cluster. The teleocidin-producing biosynthetic gene cluster 
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(tle) encodes for the same nonribosomal peptide synthetase (tleA), P-450 monooxygenase (tleB), 
and aromatic prenyltransferase (tleC) as previously identified for lyngbyatoxin. In addition, in 
certain Streptomyces, a fourth methyltransferase gene (tleD) identified downstream of the tle 
biosynthetic gene cluster has been characterized in the conversion of 1 to teleocidin B (2) (Figure 
3) (Awakawa, et al., 2014).  
In this research, immune system responses were used to investigate the potential 
relationship roles between tunicate associated Streptomyces and Styela clava. It is hypothesized in 
this research that based on previous research concerning the roles of host-associated bacteria with 
marine tunicates, the bacterium involved in the production of 1 may be involved in protection or 
modification of tunicate immune system function via incorporation of biologically relevant 
secondary metabolites as chemical defense to supplement the lack of a true adaptive immune 
system. As a result, the biosynthetic capacity of the bacteria for production of 1 and for its 
production of other biologically relevant secondary metabolites was investigated. 
Specific Aim 1: To analyze the role that the tunicate-associated bacterially-derived natural 
product plays in its interactions with associated invertebrates, the first aim involves a thorough 
analysis of immunomodulatory biological activity of bacterial extracts. To accomplish this, a novel 
cytotoxic T-lymphocyte (CTL) bioassay was employed to examine the amount of enhanced 
stimulation and/or suppression of CTL lytic granule exocytosis. An indole alkaloid natural product 
isolated from tunicate-associated Streptomyces was identified, isolated, and characterized in order 
to identify a potential mechanism for this natural product associated with marine derived bacteria 
acts through.   
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teleocidin A-1/lyngbyatoxin A (1) teleocidin B (2)  teleocidin A-2 (3) 
 
14-epi lyngbyatoxin (4)  11,14-epi lyngbyatoxin (5) 12-epi lyngbyatoxin (6) 
 
11,12-epi lyngbyatoxin (7)  12,14-epi lyngbyatoxin (8) epi lyngbyatoxin (9) 
 
Figure 3. Teleocidin derivative structures. Structures and assignment of carbon atoms for 1 
(teleocidin A-1; top left) are included with theoretically possible enantiomers including structural 
derivative 2 (teleocidin B; top middle) and naturally occurring 3 (teleocidin A-2; top right) and 4 
(14-epi lyngbyatoxin; center left) (Jiang, et al., 2014). Teleocidin B is converted from 1 catalyzed 
via the tleD methyltransferase 1,2-hydride shift of the 1 prenyl tail leading to an Si-face attack and 
cyclization of the prenyl tail to the indolactam-V benzene ring (Awakawa, et al., 2014).  
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Figure 4. Proposed biosynthesis of lyngbyatoxins A (1), B (2), and C (3). Indolactam-V 
substructure (4) biosynthesis included during the biosynthesis and serves as the precursor for 
lyngbyatoxins A-C. Figure from Edwards and Gerwick (2004). 
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 Specific Aim 2: To analyze the phylogeny of previously unidentified Streptomyces isolated 
from Styela clava and to localize the bacteria within the host Styela clava tissue, the bacterial 
genome was sequenced and compared to other Streptomyces bacterial genomes in the NCBI 
Genbank database. Bacterial genes were localized to DNA isolated from specific tissue segments 
of the tunicate host using techniques that included extraction of tunicate and bacterial DNA and 
amplification of relevant gene segments using polymerase chain reaction (PCR) based on the 
results of our investigation of the biosynthetic pathway for 1. The localization efforts were 
performed in order to identify where the bacteria were located in the tunicate. The results localized 
relevant bacteria to the interior fluid of the Styela clava, but without significant amplification of 
the genes required for the biosynthesis of 1 within the tunicate.  
13 
 
II. Methods and Materials 
A. Extract Library Preparation  
Bacteria were isolated from marine tunicate species collected from Long Island Sound, the 
Bahamas, and the Republic of Panama. Tunicates were collected either by SCUBA or removed 
from dock lines. Tunicates were rinsed either in sterile water, or 50:50 ethanol (EtOH):H2O, 
followed by rinsing in sterile-filtered sea water two times, prior to homogenization. Homogenated 
tunicate biomass was then spread onto bacterial isolate agar media (3.3% agar [w/v]; no shaking; 
room temperature; ambient light/air) with naladixic acid (Acros Organics, New Jersey, USA) (final 
concentration 20 µg/mL) and cyclohexamide (Sigma Aldrich, St. Louis, MO) (final concentration 
80 µg/mL) to reduce growth of fast-growing bacteria and fungi, respectively. Morphologically 
distinct colonies were isolated on ISP-4 agar media (Difco, Detroit, MI) and cultured in sterile 
liquid media prior to extraction. Large scale cultures were prepared by fermenting bacterial isolates 
in sterile marine broth (Difco, Detroit, MI) in a shaking incubator (200 rpm; 30 °C; ambient 
light/air) for 14 days in 500 mL broth. Once fermentation was completed, bacteria cultures were 
sonicated using a Fisher FS30 ultrasonic cleaner (Fisher Scientific, Hampton, NH; 42 KHz). Five 
grams of pre-washed Diaion HP-20 beads (Supelco, Bellefonte, PA) was added to each flask and 
allowed to shake (135 rpm) at room temperature overnight. Bacterial culture with beads were 
vacuum filtered, aqueous material eluted with water, and then extracted with consecutive washes 
of methanol and acetone. The resulting organic material was combined and concentrated in vacuo 
to dryness. 
B. Immunomodulatory Assay Screen 
For screening and PKC activity investigation, bacterial extracts were tested as described 
previously (Zhao, et al., 2016). Briefly, 10 µL of compounds (stock concentration of 10 mM in 
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DMSO; final testing concentration 100 µM in DMSO) or DMSO was added to test plates (Corning 
3603) prior to cell addition. Dynabeads coated with anti-CD3 or anti-CD8 monoclonal antibody 
(Thermo Fisher, Waltham, MA) were washed in experimental saline (ES; 155 mM NaCl, 4.5 mM 
KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM HEPES, and 10 mM glucose) according to the 
manufacturer’s protocol, and then resuspended beads were added to cell suspension at a ratio of 
one bead per cell. One hundred microliters of ES-washed TALL-104 cells (2.5 × 106/mL) were 
added to each well, mixed with DMSO or synthesized compounds, and incubated at 37 °C for 30 
min. TALL-104 cells were prepared as previously described (Zhao, et al., 2016). Ten microliters 
of stimulation solution (ES supplemented with 20 µM thapsigargin [TG] and/or 1 µM phorbol 12-
myristate 13-acetate [PMA], anti-CD3 beads, anti-LAMP) or control solution (ES + 4% DMSO, 
anti-CD8 beads, anti-LAMP) was added to each well and mixed, and the plate was incubated for 
an additional 50 min in the dark at room temperature with constant rotation. Plates were fixed with 
1% paraformaldehyde and samples were transferred to flow tubes for cytometric analysis. Samples 
were analyzed at selected time points over 1 hour and the measured responses were normalized to 
control anti-CD3 levels. Alexa647-conjugated anti-LAMP antibody (0.5 µg/mL final 
concentration) was purchased from BD Pharmingen (San Jose, CA).  
C. Isolation and Identification of Teleocidin A-1 
Styela clava tunicate specimens were collected from shallow water dock lines at Avery 
Point, CT, in May 2011 (41° 18.975 N, 72° 3.647 W) (Figure 5). The bacterium was isolated on 
sterile ISP Medium 4 agar (37 g/L; BD DifcoTM), made with Instant Ocean (33 g/L; United Pet 
Group, Blacksburg, VA) and cultured at room temperature. The morphology of AVP053U2 
resembled an actinobacterium, with a yellow base and green and white spores. AVP053U2 was 
subjected to whole genome sequencing (described below) and determined to be a new strain from 
15 
 
the genus Streptomyces (deMayo, et al., in press). Streptomyces sp. AVP053U2 was cultured for 
14 days in 500 mL of sterile marine broth (200 rpm; 30 °C; ambient light/air) and chemically 
extracted. 
For extraction, pre-washed HP-20 Diaion beads (Supelco) were added to bacterial cultures 
and left to incubate at room temperature overnight shaking at 135 RPM. Following overnight 
incubation, beads were washed with H2O (500 mL), methanol (MeOH) (1 L), and acetone (500 
mL). The MeOH and acetone layers were combined and concentrated in vacuo. The organic extract 
was initially fractionated via C18 reversed-phase (RP) solid-phase extraction (SPE) 
chromatography (Supelco) using a stepwise MeOH:H2O gradient as follows: 10% MeOH:H2O 
(fraction A), 25% MeOH:H2O (fraction B), 50% MeOH:H2O (fraction C), 75% MeOH:H2O 
(fraction D), and 100% MeOH (fraction E). A final wash of 100% acetone (fraction F) was used 
to clean any remaining material from the column. All fractions were concentrated to dryness in 
vacuo. Fractions were then subjected to gradient liquid chromatography–mass spectrometry (LC-
MS) characterization on an Agilent 6130 ESI single quadrupole mass spectrometer comprised of 
an Agilent G1311 quaternary pump, G1322 degasser, and G1315 diode array detector and coupled 
to an Agilent 1200 series high-performance liquid chromatography (HPLC) system (Agilent 
Eclipse XDB-C18; 5 µm; 4.6 × 150 mm column). Initial LC-MS was performed using a 40%–100% 
ACN:H2O gradient (0.1% formic acid) solvent system for 30 min. 
During secondary screening, fraction E exhibited the most potent activity and was further 
investigated. Compound 1 (1.4 mg) was isolated by C18 RP-HPLC using an isocratic method of 
35% H2O and 65% ACN (Agilent Eclipse XDB-C18; 5 µm; 4.6 × 150 mm column; 1 mL/min flow 
rate, rt 12 minutes). Nuclear magnetic resonance (NMR) spectra of 1 were collected in DMSO-d6 
on a Varian INOVA 600 MHz instrument including 1H, COSY, HSQC, and HMBC.   
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Figure 5. Map of southeastern Connecticut. Collection location was at University of Connecticut 
Avery Point campus (Groton, CT) (Google Maps, 2016). 
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NMR spectra for 13C experiments were collected on a 500 MHz Bruker AVANCE at 125 MHz. 
Chemical shifts were reported in δ units (ppm) using DMSO-d6 as the internal standard for signals. 
High resolution mass spectrometry (HRMS) was performed at the University of Connecticut Mass 
Spectrometry Facility on an AccuTOF (JEOL) using a DART (IonSense) ionization source. Optical 
rotation experiments were collected on a JASCO P-2000 polarimeter (c 0.13 g/100mL, MeOH, 
26 °C). CD spectra was collected on an Applied Photophysics Pi-star 180 circular dichroism 
spectrapolarimeter (Leatherhead, Surrey, UK) (c 0.5 mg/mL, MeOH, 21 °C). 
D. DNA Extraction and Genome Sequencing 
Bacterial DNA. Colonies of sporulated bacteria were cultured on Difco ISP Medium 4 agar 
as described above, removed with sterile loops into sterile 1.5 mL microcentrifuge tubes 
(Eppendorf), and DNA was extracted using a Wizard Genomic DNA Purification Kit (Promega 
Corporation, Madison, WI) according to the manufacturer’s protocol. The Illumina TruSeq Nano 
DNA Library Preparation Kit was used to fragment DNA (200 ng), attach adapter sequences, and 
size selected, according to manufacturer’s protocol (UConn MARS facility). Libraries were 
validated and an Agilent Bioanalyzer High Sensitivity chip was used to calculate mean insert 
length (UConn MARS facility). Libraries were sequenced on the Illumina MiSeq using v2 2x250 
base pair kit, assembled with A5-miseq pipeline v20140113 (Coil, et. al. 2015), checked for 
contamination with Blobology pipeline (Kumar, et al., 2013), and annotated with Prokka v1.10 
(Torsten, 2014) (Jonathan Klassen, UConn Dept. of Molecular and Cellular Biology). Phylogenetic 
analysis of the bacteria was completed using the ORFcor bioinformatics pipeline (Klassen and 
Currie, 2013) (Jonathan Klassen, UConn Dept. of Molecular and Cellular Biology).  
Tunicate DNA. Styela clava individuals were collected from shallow water dock lines at 
Avery Point, CT, (41° 18.975 N, 72° 3.647 W). Upon collection, individual tunicates were rinsed 
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with seawater and Millipore filtered DI water or 50:50 EtOH:H2O to sterilize the outer surface of 
the tunic, leaving internal bacteria embedded within the tissue, and relaxed in a solution of 10% 
menthol in DI water. Tunicates were transported back to the lab where tissue samples were 
dissected. The tissue dissections included tunic (T), internal gut (G), and internal fluid material 
that was drained and collected upon initial incision (F) (Figure 6).  
Following dissection, tunicate specimens were frozen at -20 °C until DNA extraction. DNA 
extractions were performed based on a previously published protocol for isolating DNA from 
tunicates (Schmidt and Donia, 2009). Tunic tissue samples were divided into small pieces 
approximately 4-5 mm2 in size. Organ samples were lyophilized and ground together using a 
mortar and pestle and suspended in 1X TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0). 
Lysozyme was added to the buffer-homogenate solution to a final concentration of 2 mg/mL and 
incubated at 30 °C for 30-60 minutes. (Ethylenediaminetetraacetic acid) EDTA was added to a 
concentration of 0.1M, Proteinase K solution was added to a final concentration of 0.2 mg/mL, 
and the homogenate was incubated at 30 °C for 5 minutes. 10% Sodium dodecyl sulfate (SDS) 
solution was added to a final concentration of 1% and the homogenate solution was incubated 
tilted at 90° at 37 °C overnight. Ten percent (v/v) NaCl solution (5M) and eight percent (v/v) CTAB 
solution [10% CTAB (hexadecyltrimethyl ammonium bromide) in 0.7 M NaCl] was added to the 
solution and incubated for 20 to 60 minutes at 65 °C. To extract DNA, 500 µL of homogenate 
solution was aliquoted into sterile 1.5 mL centrifuge tubes, mixed with 420 µL of both deuterated 
chloroform and saturated phenol solution, and vortexed to mix. Solution was centrifuged at 17,000 
x g for ten minutes and the top (aqueous) layer was removed. Aqueous layer was mixed with 0.1 
volumes of 3 M sodium acetate and 0.6 volumes of ice-cold isopropanol. Tube was mixed by 
inversion until DNA precipitated and centrifuged at 17,000 x g for two minutes to pellet the DNA.   
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Figure 6. Photos of dissected Styela clava: A) whole Styela clava prior to dissection; B) dissected 
tunic tissue (T) and C) dissected gut/GI tract tissue (G). Not pictured: internal fluid (F). 
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The supernatant was aspirated and the DNA pellet was washed with 300 µL of 70% EtOH. The 
tube was centrifuged at 17,000 x g for two minutes to re-pellet the DNA, EtOH was aspirated, and 
the DNA was left to dry for ten minutes. Dried DNA was resuspended in TE buffer and measured 
for concentration and purity via NanoDrop (ThermoFisher, USA). Tunicate internal fluid (F) was 
filtered onto 0.22 µm nitrocellulose filters (EMD Millipore, Darmstadt, Germany) and DNA was 
extracted using a MoBio PowerWater DNA Isolation Kit (MoBio Laboratories, Carlsbad, CA, 
USA) according to the manufacturer’s protocol. DNA concentration and purity was quantified 
using a NanoDrop (ThermoFisher, USA).  
Primer Design. Base pair sequences for each protein gene involved in teleocidin 
biosynthesis and for the 16S rRNA gene were identified and primer pairs were designed for a 
conserved region within each domain for future PCR amplification experiments. Primers were 
designed for amplification of a segment from the 16S rRNA gene specific for Streptomyces related 
organisms based on the sequencing results mentioned previously, and for amplification of a 
segment from the 18S rRNA gene specific for Styela clava. Custom PCR primers were designed 
for amplification of Streptomyces 16S rDNA, Styela clava 18S rDNA, and teleocidin biosynthesis 
gene segments using Primer3 (v 4.0.0) primer identifier software (Untergasser, et al., 2012) 
(Koressaar and Remm, 2007) (Table 1). Parameters for primer identification included primer size 
(18-23bp), melting temperature (57.0-62.0 °C), and GC% (30.0-70.0). Primers 27F and 1391R 
were used for universal amplification of 16S rRNA gene (Frank, et al., 2008) (Beckers, et al., 2016). 
Amplicon length was 1.2 kbp. Primers designed specifically for the Streptomyces 16S rRNA 
sequence were produced based on the genome of Streptomyces sp. AVP053U2. Primers for 
teleocidin biosynthesis were designed for a conserved, easily amplifiable region of each DNA 
segment involved in teleocidin biosynthesis identified from the genome of Streptomyces sp. 
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AVP053U2. Primer specificity was validated using Primer-BLAST. Amplicon lengths were 
designed as follows: tleA – 201 bp, tleB – 250 bp, tleC – 223 bp, MbtH-like protein – 182 bp. 
Primers for amplification of 18SrDNA were designed based on sequence for S. clava 18S rRNA 
(Genbank Accession: AH001758). Amplicon lengths were designed for 235 bp.  
Polymerase Chain Reaction. PCR reactions were prepared with GoTaq Green MasterMix 
(Promega Corporation, Madison, WI, USA) according to the manufacturer’s instructions. Final 
concentrations of dNTPs, forward and reverse primers, and MgCl2 were 200, 0.4 µM, and 1.5 mM, 
respectively. Master Mix was prepared in a proprietary buffer at pH 8.5 combined with yellow and 
blue dyes for visualization during gel electrophoresis. Varying concentrations of template DNA 
were added in order to optimize amplification and visualization (Table 2). 
Reaction protocols for PCR experiments to amplify bacterial 16S rDNA were as follows: 
2 minutes of denaturing at 96 °C, followed by 30 cycles of 45 seconds at 96 °C (denaturing), 30 
seconds at 56 °C (annealing), and 2 minutes at 72 °C (elongation), and a final extension for 5 
minutes at 72 °C. The reaction protocol for PCR experiments for amplifying eukaryotic 18S rDNA 
segments were performed as follows: 2 minutes of denaturing at 95 °C, followed by 35 cycles of 
1 minute at 95 °C (denaturing), 1 minute at 40 °C (annealing), and 1.5 minutes at 72 °C 
(elongation), and a final extension for 7 minutes at 72 °C. PCR Products were analyzed via agarose 
gel electrophoresis stained with ethidium bromide. Photographs of the stained agarose gel PCR 
products were collected using a UVP GelDoc-It 300 Imaging System (Upland, CA, USA). PCR 
reaction positive controls for amplification of 18S rDNA included DNA extracted from S. clava. 
Positive controls for 16S rDNA PCR reactions were DNA from Streptomyces sp. AVP053U2 and 
E. coli. Negative control for gut and tunic tissue DNA reactions was 1X TE Buffer. Negative 
control for fluid and environmental water reactions was solution PW6 (MoBio laboratories, 
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Carlsbad, CA, USA). PCR products were cleaned using a Promega Wizard SV Gel/PCR Clean-up 
Kit (Promega Corporation, Madison, WI, USA) according to the manufacturer’s instructions. 
Clean double-stranded PCR products were analyzed for concentration and purity via NanoDrop 
(ThermoFisher, USA) for the ratio of light absorbance at 260 nm and 280 nm (Glasel, 1995), and 
Sanger sequenced for BLAST analysis (megablast; expect threshold: 10; match/mismatch scores: 
1, -2; linear gap costs) to ensure successful amplification of the intended sequence(s) (Kendra 
Maas, UConn MARS Facility). 
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Table 1. Primer sequences for PCR experiments. The primer sequences were used for amplification 
of housekeeping genes identified in tunicate and bacterial DNA. “MbtH-like gene” refers to the 
annotation for the fourth gene involved in teleocidin biosynthesis. 
Primer Name Primer sequence (5'-3')  Target DNA Sequence 
27F AGAGTTTGATCCTGGCTCAG 16S rDNA 
1391R GACGGGCGGTGTGTRCA 16S rDNA 
 
AVPfor3 AAGTGACGGTACCTGCAGAA 16S rDNA 
AVPrev3 TCACCGCTACACCAGGAATT 16S rDNA 
 
S.clava18Sfor ATTCTTGGATCGGCGGAAGA 18S rDNA 
S.clava18Srev ATTGCTCAATCTCGTGTGGC 18S rDNA 
 
tleAfor2 TCAGGACCTATCGTTCGAGA tleA 
tleArev2 AGGCTCAGTGAAAGGTCGAA tleA 
 
tleBfor2 GATGACGGAGGAGGAGATCG tleB 
tleBrev2 GGGTGAACAGGACGTACAGA tleB 
 
tleCfor2 GGCATGCCTTTCGAAGTATC tleC 
tleCrev2 CGTGGGAGAGCGAGAAGTAT tleC 
 
MbtHfor2 CTTTCTCGGTGCTGGTCAAC MbtH-like gene 
MbtHrev2 AGAACCGGTCGTAGTGCTC MbtH-like gene 
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Table 2. Template DNA used for PCR experiments. PCR reactions were optimized and visualized 
via gel electrophoresis. DNA quantified via NanoDrop UV detection. 
Template DNA Primers used Total amount of DNA per 
50 µL reaction (ng) 
AVP053U2 AVP16Sfor3/AVP16Srev3 707 
AVP053 – Fluid AVP16Sfor3/AVP16Srev3 25 
AVP053 – Fluid 27F/1391R 25 
AVP053 – Tunic tissue SCLAVA18Sfor/SCLAVA18Srev 11 
Sea Water AVP16Sfor3/AVP16Srev3 9 
Sea Water 27F/1391R 9 
E. coli 27F/1391R 10 
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III. Results 
A. Screening of Tunicate-Associated Bacterial Extracts 
 A library of 294 extracts prepared from tunicate-associated bacteria was screened for their 
ability to enhance or inhibit CTL granule exocytosis. Using the assay described by Zhao et. al. 
(2016) yielded a hit for stimulation of lytic granule exocytosis (Figure 7A). Treatment with the 
extract enhanced lytic granule exocytosis by nearly three times the physiological level. The extract 
had no effect on cells that were not pre-stimulated by beads with anti-CD3 antibody. Repetition of 
the experiment confirmed the granule exocytosis augmenting effect.  
The extract was fractionated using a reversed-phase solid phase extraction (SPE) column 
(Supelco, Bellefonte, PA) (Figure 8), and the activity was examined for each of the individual 
fractions (Figure 7B). Upon initial screening, fraction E was the most potent prefraction, yielding 
a five-fold enhancing effect of cells stimulating by CD3 beads as measured cytometrically for anti-
LAMP fluorescence. This result is comparable to treatment with TG and PMA on CD3 stimulated 
cells. Fluorescence values for cells stimulated with anti-CD3 antibodies and fraction E reached 
100 relative fluorescence units (RFU), while cells stimulated with anti-CD3 antibodies combined 
with TG and PMA reached 120 RFU. Fraction E was chosen for compound isolation via RP-HPLC 
as a result of the easily distinguishable peaks. The peak eluting at a retention time of 12 min was 
isolated as a pure compound as described below, and coded as E1 (Figure 9), which was found to 
enhance lytic granule exocytosis with an EC50 of approximately 1 nM (Figure 7C).  
To determine the mechanism of action for lytic granule exocytosis as a result of treatment 
with E1, cells were treated for 90 minutes with either E1 or PMA in order to compare levels of 
enhancement. PKC activity enhancement was investigated further because although calcium influx 
and activation of PKC and ERK are required for CTL granule exocytosis (Pores-Fernando and 
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Zweifach, 2009), limited exocytosis was observed in cells not treated with beads when treated with 
E1. Activity-guided fractionation of the active extract led to the isolation of E1, exhibiting potent 
stimulatory activity on the PKC pathway independent of calcium influx activity. Imaging of live 
cells using the calcium-sensitive probe Fura-2 confirmed granule exocytosis activity regardless of 
intracellular calcium concentration. Dose-response measurements of PKC activity identified the 
enhancement levels of E1 and PMA across three concentrations ranging from 0.01 to 200 nM 
(Figure 7D). Furthermore, treatment with E1 resembled that of treatments whose effects occur 
independent of intracellular calcium concentration (Figure 10). Fits to the Hill equation indicate 
that E1 activated PKC with an EC50 of 6.9 nM, almost as potent as PMA (EC50 = 3.6 nM).  
B. Identification of Teleocidin A-1 
Structure elucidation of E1 utilized a series of one-dimensional (1D) and two-dimensional 
(2D) NMR experiments (Figures 11-15, Table 3) in addition to mass spectrometric analysis. HRMS 
of E1 identified a molecular ion peak at m/z 438.3112 [M + H]+ (Figure 16) consistent with the 
formula C27H39N3O2. The molecular formula was indicative of ten degrees of unsaturation. Partial 
structure elucidation and comparison with literature NMR data (Jiang, et al., 2014) led us to 
identify E1 as a derivative of teleocidin. The 1H spectra indicated several aromatic signals around 
7.0 ppm consistent with a heterocyclic aromatic compound. In addition, two distinct downfield 
signals highlight heterocyclic amido and/or hydroxyl protons. Two pairs of signals appeared as a 
doublet of doublets, indicating close proximity to stereogenic carbons with enantiotopically 
distinct protons with shifts at δH 2.93 and δH 3.04 ppm, and δH 5.03 and δH 5.09 ppm. 1H-13C HSQC 
correlated these two proton signals to carbons with signals at δC 34.1 and δC 112.2 ppm respectively. 
The downfield shifts of the latter proton and carbon signals indicated sp2 hybridization. Further 
analysis of the downfield proton signals at δH 5.03 and δH 5.09 via 1H-1H COSY showed no   
27 
 
 
Figure 7. Detection and activity-guided isolation of an exocytosis-enhancing PKC-activating 
compound. (A) Screening of bacterial extracts measuring for anti-LAMP fluorescence. Red spots 
represent cells stimulated with CD3 beads only. Blue spots represent cells stimulated with CD8 
beads only. Black spots represent cells treated with CD3 beads and bacterial extracts. The 
highlighted black spot represents the most successful hit and was discovered to contain 1. (B) 
Prefractions of the hit extract were further examined in the same assay as in A. Anti-LAMP 
fluorescence values of cells treated with prefractions A-F are compared to CD8 (blue), CD3 (red), 
and CD3+TG+PMA (pink) controls. (C) Dose-response measurement of the first compound 
isolated from prefraction E measuring for anti-LAMP fluorescence. (D) Comparisons of dose-
response measurements for anti-LAMP fluorescence between cells treated with E1 (circles) and 
PMA (squares). Experiments were conducted three times in C and twice in D (Zhao, et al., 2016).   
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Figure 8. Chemical structure schematic. Organic solvents used for chemical extraction (MeOH and 
acetone) and percent CD3 bead enhancement for each extract and fraction tested are included. 
AVP053U2 was cultured for 14 days prior to chemical extraction overnight and fractionation into 
six prefractions. Fraction E was subject to HPLC using an isocratic method of 65% acetonitrile 
over 30 minutes to elute the peak of interest, E1, at 12 minutes. RP-SPE: reverse-phase solid phase 
extraction; HPLC: high performance liquid chromatography. 
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mAU 
           
Figure 9. LC chromatogram of Fraction E containing teleocidin A-1. HPLC chromatogram of 
fraction E with the peak E1 eluting at approximately 12 minutes. Method developed as 65:35 
ACN:H2O with 100 µL solution injected at 2 mg/mL. Blue trace represents absorbance at 254 nm, 
red trace represents absorbance at 209 nm, and green trace represents absorbance at 299 nm. 
Absorbance measured in mAU.  
  
Time 
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Figure 10. Treatment with anti-CD3 beads provide additional capacity for lytic granule exocytosis. 
(A) Histograms of anti-LAMP fluorescence for the conditions indicated. Results from treatment 
with TG, which acts through increase of calcium influx, are similar regardless of the pre-
stimulation with anti-CD3 beads. Treatments with PMA, which stimulate granule exocytosis 
through PKC activation (independent of calcium influx), yield higher anti-LAMP fluorescence 
values. (B) Plots of the geometric mean of anti-LAMP fluorescence from a 96-well plate 
containing cells and anti-CD8 beads (circles), anti-CD3 beads (squares), anti-CD3 beads + PMA 
(diamonds), and anti-CD3 beads + TG + PMA (triangles). Responses from cells assessed as bound 
to beads by scatter are shown on top. Responses from cells that are not bound to beads are on the 
bottom. Experiments were conducted more than three times. TG and PMA were used at final 
concentrations of 2 µM and 100 nM, respectively (Zhao, et al., 2016). 
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correlation with other proton signals, indicating a terminal methylene adjacent to an enantiotopic 
proton. Upfield carbon signals at δC 17.2 and δC 24.2 ppm correlated with singlet proton signals at 
δH 1.38 and δH 1.42 ppm respectively. The singlet splitting pattern of these proton signals indicate 
two terminal methyl protons both adjacent to an sp2 hybridized quaternary carbon center. 1H-13C 
HMBC spectroscopy confirmed the proximity of the signals at δH 1.38 and δH 1.42 ppm to a 
quaternary carbon signal at δC 130.4 ppm. Additional upfield proton signals at δH 0.51 and δH 0.81 
ppm were both shown to correlate to a proton signal at δH 2.44 ppm with doublet splitting patterns, 
indicating a dimethyl substituted methyl group. Further 1H-13C HSQC analysis identified proton 
signals at δH 3.35 and 3.4 ppm and contain multiplet splitting patterns that correlate to a carbon 
signal at δC 63.9 ppm. The downfield tendencies for both the proton and carbon signals indicate 
proximity an electronegative heteroatom. In addition, examination of the 1H-13C HSQC spectra 
identifies one far downfield proton signal that appears not to correlate with a carbon signal, which 
can attributed to an electronegative heteroatom. 1H-1H COSY analysis indicated that the only 
proton signal which correlates to the furthest downfield proton signal at δH 9.86 ppm belongs to a 
proton signal at δH 6.93 ppm identifying proximity to an electronegative heteroatom. Finally, 
analysis of the 1H-13C HMBC spectra identifies two multiple-bond carbon correlations to the 
proton signal at δH 9.86 ppm, indicating that two carbons are adjacent to the heteroatom whose 
proton signal appears at δH 9.86 ppm. These results indicate that the heteroatom is likely a nitrogen. 
To determine the absolute stereochemistry of E1, optical rotation and circular dichroism 
(CD) experiments were performed. Both experiments were utilized in order to confirm the 
stereospecific orientation of all three predicted chiral centers. Optical rotation results indicated a 
degree of rotation of [α]D 20 = −35°, consistent with literature values of teleocidin A-1 (Jiang, et 
al., 2014). For additional confirmation of the configuration of E1, CD spectra data were obtained 
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in MeOH as follows: [θ]230 = −655, [θ]234 = 4892, [θ]259 = −24189, [θ]314 = −1290, and [θ]328 = 
−3183 (Figure 17), confirming that compound E1 is consistent with the planar and stereo-structure 
of teleocidin A-1 (Jiang, et al., 2014). 
C. Bacterial DNA and Genome Sequencing 
Investigation of the whole genome associated with the bacteria was of particular interest 
after isolating and identifying 1. The structure of 1 is consistent with metabolites produced from 
sophisticated non-ribosomal peptide synthetase (NRPS), terpene, and polyketide synthase (PKS) 
pathways. As a result, the relevant biosynthetic gene clusters associated with the production of 1 
were identified, in addition to other biologically relevant gene sequences. Genomic DNA was 
extracted from a pure culture of bacteria and sequenced as described above. Whole genome 
sequencing identified the bacterium as a novel strain of Streptomyces sp and was delineated 
AVP053U2. Bi-directional average nucleotide identity (ANI) calculated to be 99.68% identical to 
Streptomyces sp. TP-A0873 (NCBI Accession Number: BBNN00000000) (Goris, et al., 2007). 
The genome was sequenced to 153X coverage containing 7,759,417 nucleotides with 183 scaffolds. 
The total GC content was identified as 71.85% with N50 = 137,942 bp.  
The sequence was examined using antiSMASH 3.0.4 (Antibiotics and Secondary 
Metabolite Analysis Shell) to identify relevant secondary metabolite gene clusters (Weber, et al., 
2015). Forty-six putative clusters were identified with six sharing 100% identity with previously 
reported clusters, including those for teleocidin-B, isorenieratene, albaflavenone, antimycin, γ-
butyrolactone and ectoine biosynthesis. The remaining clusters included 11 NRPS, seven T1-PKS, 
six terpene, three lantipeptide, two NRPS/T1-PKS, two siderophore, one each of 
amgylccycl/NRPS, T1-PKS/transAT-PKS/NRPS, terpene/T2-PKS, indole/NRPS, melanin, 
NRPS/lantipeptide, butyrolactone/T1-PKS, butyrolactone, nucleoside, ectoine, bacteriocin,   
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Table 3. NMR chemical shifts and splitting patterns for peaks in 1H and 13C spectra. Proton and 
carbon peaks identified are in Figure 11. All shift units reported in ppm. Carbon numbers correlate 
to labeled diagram for 1 in Figure 3. 
 No. δC δH Splitting Pattern 
1 17.2 1.38 s 
2 19.5 0.51 d 
3 21.4 0.81 d 
4 22.9 1.57 m   
1.79 m 
5 25.4 1.58 s 
6 24.2 1.42 s 
7 28 2.44 m 
8 32.6 2.77 s 
9 34.1 2.93 dd   
3.04 dd 
10 38.4 1.76 m   
1.96 m 
11 42.9 
  
12 55.6 3.98 m 
13 63.9 3.35 m   
3.4 m 
14 70.3 4.24 d 
15 105 6.35 d 
16 112.2 5.03 dd   
5.09 dd 
17 112.8 
  
18 118.6 
  
19 119.6 6.79 d 
20 122.5 6.93 d 
21 121.6 
  
22 124.6 5.01 m 
23 130.4 
  
24 136 
  
25 145.7 
  
26 146.3 6.12 m 
27 171.7 
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Figure 11. 1H NMR spectra of 1 (teleocidin A-1). Spectra was collected at 600 MHz in DMSO-d6. 
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Figure 12. 13C NMR spectra of 1 (teleocidin A-1). Spectra was collected at 125 MHz in DMSO-d6. 
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Figure 13. 1H-1H COSY NMR spectra of 1 (teleocidin A-1). Spectra was collected in DMSO-d6.  
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Figure 14. 1H-13C HSQC NMR spectra of 1 (teleocidin A-1). Spectra was collected in DMSO-d6. 
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Figure 15. 1H-13C HMBC NMR spectra of 1 (teleocidin A-1). Spectra was collected in DMSO-
d6.  
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Figure 16. High resolution mass spectra of 1 (teleocidin A-1). A mass of 437.3112 Da was identified based on the protonated m/z signal 
of 438.3112 Da. Molecular formula determined as C27H39N3O2.  
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Figure 17. Circular Dichroism (CD) spectra of 1 (teleocidin A-1). Top: CD spectra data were obtained in MeOH as follows: [θ]230 = 
−655, [θ]234 = 4892, [θ]259 = −24189, [θ]314 = −1290, and [θ]328 = −3183. Optical rotation results indicated an overall degree of rotation 
of [α]D 20 = −35°. Bottom: CD spectra reported for lyngbyatoxin A (teleocidin A-1, 1; blue dash line) and 12-epi-lyngbyatoxin A (red). 
Figure modified from Jiang, et. al. (2014).  
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NRPS/ladderane-arylpolyene, T3-PKS, and 2 unidentified domains. Clusters for kirromycin and 
candicidin that are separated for the same metabolite can be more appropriately joined together. 
Of the biosynthetic gene clusters identified, fewer than half are shared with those identified from 
an antiSMASH analysis of Streptomyces sp. TP-A0873. Inspection of the identified biosynthetic 
gene cluster for teleocidin-B production yielded the presence of one dimodular non-ribosomal 
peptide synthetase (tleA), one cytochrome P450 hydroxylase (tleB), a tryptophan dimethylallyl 
transferase (tleC), and an MbtH-like protein (Figure 18). However, the final enzyme necessary for 
terpene cyclization from 1 to 2 (tleD) was not identified in the downstream region of the gene 
cluster. The biosynthetic cluster assigned by antiSMASH to represent teleocidin B biosynthesis in 
Streptomyces sp. AVP053U2 also lacked the tleD gene needed for terpene cyclization. The genome 
sequenced was deposited into GenBank under the accession number LMTQ00000000.  
D. Localization of Teleocidin Biosynthesis and Housekeeping Gene Regions 
PCR amplification experiments were performed in DNA stocks taken from cultures of pure 
Streptomyces sp. AVP053U2 and from DNA isolated from Styela clava individuals collected from 
Avery Point, CT including the original voucher specimen that AVP053U2 was originally isolated 
from. These experiments aimed to evaluate the presence or absence of bacteria known for 
secondary metabolism of natural products with drug-like properties and specifically for teleocidin 
biosynthesis. Successful amplification of universal bacterial 16S rRNA genes and custom 16S 
rRNA gene segments were observed in DNA isolated from Streptomyces sp. AVP053U2, internal 
fluid collected from tunicate specimens, and environmental sea water samples (Figure 19). Internal 
fluid was isolated during dissection by draining and collecting all fluid material after excising the 
posterior end of the tunicate. Amplification of S. clava 18S rRNA housekeeping genes was 
successful in DNA isolated from S. clava tissue segments (Figure 19, Table 4). Teleocidin   
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Figure 18. Comparison of biosynthetic gene clusters responsible for teleocidin. (Top) Biosynthetic 
gene cluster responsible for the production of teleocidin from the antiSMASH analysis of 
Streptomyces sp. AVP053U2. Figure represents genes based on the sequenced genome of 
AVP053U2. Putative biosynthetic genes are colored red, regulation-related genes are colored green, 
and other genes are colored gray. A: tleA – dimodular non-ribosomal peptide synthetase. B: tleB – 
cytochrome P450. C: tleC tryptophan dimethylallyl transferase. D: MbtH-like protein. (Middle) 
Database alignment of teleocidin biosynthetic gene cluster. A: tleA – dimodular non-ribosomal 
peptide synthetase. B: tleB – cytochrome P450. C: tleC tryptophan dimethylallyl transferase. D: 
MbtH-like protein. (Bottom) Domains identified for tleA gene segment. A: AMP-binding domain, 
nMT: n-methyl transferase, C: condensation domain, TD: threonine deaminase (Weber, et al., 
2015) 
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biosynthesis amplification experiments were successful in DNA extracted from Streptomyces sp. 
AVP053U2 (Figure 20). Sequences of PCR products amplified with primers 
AVP16Sfor3/AVP16Srev3 and S.CLAVA18Sfor/S.CLAVA18Srev were submitted for BLAST 
analysis to ensure successful amplification of the intended sequence(s). Amplicon sequences of 
AVP053U2 16S rDNA aligned with organisms of the genus Streptomyces (BLAST E-value: 
30,000; NCBI match Accession number: CM003601). In addition, as expected, Styela clava 18S 
amplicon sequences from tunicate tissues aligned with sequences for Styela clava 18S rDNA 
(BLAST E-value: 30,000; NCBI match Accession number: AH001758).  
Primer BLAST analysis was used to identify other known organisms with similar DNA 
segments that could have been amplified during the reaction. Primer BLAST results for primers 
AVP16Sfor3/AVP16Srev3 indicate amplification of genomes that include, but are not limited to S. 
anulatus, S. coelicolor, Streptomyces sp. Root66D1, and Streptomyces sp. Root1310. AntiSMASH 
analysis of these additional genome assemblies highlight biosynthetic gene clusters for NRPS/PKS 
pathways that result in metabolites such as actinomycin, cyclohexamide, albaflavenone, cinerubin 
B, antimycin, and actinorhodin (Table 5). These biosynthetic gene clusters are also found in the 
genome assembled from Streptomyces sp. AVP053U2 (Table 6).  
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Figure 19. PCR amplification experiments of housekeeping genes in tunicate tissue. Amplicons 
analyzed via gel electrophoresis on a 1% agarose gel stained with ethidium bromide (0.5 µg/mL). 
Gel was run at a constant 80V for 1 hour. (A) S. clava 18S rDNA amplifications. Styela clava DNA 
used as positive control. 1X TE Buffer used as negative vehicle control for tunic and gut tissue 
DNA samples. (B) Universal 16S rDNA amplifications. E. coli DNA used as positive control. 1X 
TE Buffer used as a negative control for tunic and gut tissue DNA samples. 10mM Tris-HCl 
(Solution PW6 [MoBio Labs]) used as a negative control for both internal fluid and water sample 
DNA samples. Amplification experiments for internal fluid and for water sample DNA with 
universal 16S rDNA were performed separately and thus have two separate negative control runs. 
Samples with universal bacteria 16S rDNA were also examined for 16S rDNA of AVP053U2-like 
bacteria in C. (C) 16S rDNA region directed for Streptomyces sp. AVP053U2-like bacteria. DNA 
from Streptomyces sp. AVP053U2 used as a positive control. 1X TE Buffer used as a negative 
control for gut tissue DNA and 10mM Tris-HCl (Solution PW6 [MoBio Labs]) used as a negative 
control for internal fluid and water sample DNA.  
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Figure 20. PCR amplification experiments of teleocidin biosynthesis genes. Experiments were 
conducted using DNA extracted from tunicate internal fluid and surface sea water. AVP053U2 
used as a positive run control. 10 mM Tris-HCl (Solution PW6 [MoBio Labs]) used as a negative 
vehicle control. Conserved segments of each biosynthetic gene cluster were amplified. Entire gel 
included in Appendix B. 
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Table 4. PCR amplification results for presence or absence of 18S and 16S rRNA genes in extracted 
DNA. The experiments for identifying presence or absence of 18S rDNA and 16S rDNA regions 
are in genomic DNA samples isolated from tunicates, bacteria, and filtered sea water. “X” denotes 
successful amplification. “ – ” denotes unsuccessful amplification. 
Sample S. clava 18S 
rRNA 
Universal 16S 
rRNA 
Streptomyces 
specific 16S rRNA 
Teleocidin 
Biosynthesis 
Tunicate Tissue  X  - - - 
Tunicate Fluid - X X - 
AVP053U2 - X X X 
Sea Water - X X - 
E. coli - X - - 
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Table 5. Closely related strains of Streptomyces identified via Primer BLAST and their associated 
biosynthetic gene clusters. Bacterial strains were investigated using antiSMASH for biosynthetic 
gene clusters.  
 
  
Additional genomes 
identified 
NCBI Accession 
Number 
Featured 
sequences 
Biosynthetic gene clusters identified 
Streptomyces anulatus 
strain ATCC 11523 
CM003601 16S rRNA Actinomycin, cyclohexamide, oxazolomycin, 
griseobactin, coelichelin, incednine, 
herboxidiene, streptolydigin, borrelidin, 
steffimycin, ectoine, desferrioxamine B, 
tetronasin, skyllamycin, enduracidin, 
rabelomycin, landomycin, 2- 
methylisoborneol, nonactin, hopene, 
legonaridin, actinomycin, melanin, 
daptomycin 
    
Streptomyces sp. 
Root66D1 
LMHG01000001 16S rRNA Cinerubin B, istamycin, xantholipin, 
venezuelin, quartomicin, platencin, 
friulimicin, desferrioxamine B, hopene, 
ectoine, versipelostatin, 2-methylisoborneol 
    
Streptomyces sp. 
Root1310 
LMEQ01000001 16S rRNA Albaflavenone, antimycin, ectoine, 
lactonamycin, desferrioxamine B, 
meridamycin, hopene, akaeolide, 
furaquinocin A, albaflavenone, alnumycin, 
indanomycin, endophenazine, caprazamycin, 
laspartamycin, rifamycin, nigericin, 
labyrinthopeptin, pyridomycin, legonaridin, 
mitomyicn, melanin, phoslactomycin, 
scabichelin, herbimycin 
    
Streptomyces coelicolor NC_003888 16S rRNA Leinamycin, isorenieratene, sanglifehrin A, 
coelichelin, informatpeptin, herboxidiene, 
ectoine, lactonamycin, desferrioxamine B, 
albaflavenone, actinorhodin, spore pigment, 
undecylprodigiosin, enduracidin, coelimycin, 
nogalamycin, hopene, arsenopolyketides, 
ravidomycin, coelibactin 
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IV. Discussion 
A. Screening of Tunicate-Associated Bacterial Extracts 
The assay described previously represents an evaluation of cytotoxic T-lymphocyte (CTL) 
lytic granule exocytosis and suppression as a result of stimulation with small molecules. 
Stimulation with addition of TG and PMA help guide the evaluation of specific mechanism of 
action for enhancement of lytic granule exocytosis. Investigation of secondary metabolites have 
often led to the identification of novel and interesting small molecule therapeutics (Li and Vederas, 
2009). A library of unknown bacterial secondary metabolite extracts was successfully screened, 
identifying a potent PKC enhancing molecule whose mechanism of action was further investigated. 
In preliminary testing, higher testing concentrations of compound E1 yielded low levels of granule 
exocytosis, leading us to believe that E1 augmented immune system response by limiting PKC 
activation. However, previous reports of cell degradation as a result of PKC augmenting 
compounds indicate that in response to PKC activators, PKC over-activation and prolonged 
exposure have been demonstrated to lead to ubiquitination and degradation (Lu, et al., 1998). Our 
initial data suggests that an increase in concentration of E1 leads to cell death as a result of PKC 
over-activation and results in an apparent inhibitory effect. Repeat experiments indicated that at 
lower concentrations E1 was responsible for PKC activation independent of intracellular calcium 
concentration (Figure 10). As a result, E1 is an unlikely candidate for treatment of immune 
disorders because of its over-activation potential.  
Elucidation of the pure compound structure involved thorough analysis of NMR, HRMS, 
optical rotation, and CD spectra. Two-dimensional NMR spectra were used to assign proton and 
carbon nuclei associations through space and across multiple bond correlations. Optical rotation 
and CD experiments are used to analyze molecular three-dimensional orientation, and confirmed 
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its conformation as teleocidin A-1 (1). A mass of 437.3112 Da was determined from the protonated 
m/z of 438.3112 Da. The chemical formula was consistent with ten degrees of unsaturation 
attributed to three ring structures, and seven pi bonds throughout the molecule. Data collected 
through NMR and polarimetry experiments coupled with the mass spectra helped to identify the 
overall structure as known PKC-activating metabolite teleocidin A-1. Three chiral carbons in the 
overall structure allow for a total of eight possible configurations and enantiomers. Optical rotation 
and CD data were able to identify the three-dimensional structure as the previously isolated 
metabolite 1 (Figure 17). Comparison of the remaining NMR data was in close agreement with to 
reported literature data for 1. 
Comparison of the dose-response measurements for PKC activation between PMA and 1 
(Figure 7D) led us to investigate the specific mechanism of action of 1 in complex with PKC 
activation. Previous research for secondary activation of PKC with phorbol esters such as PMA 
indicate binding events within the C1B domain of PKC isoforms (Zhang, et al., 1995). In fact, 
docking experiments comparing the pharmacophore model of the indolactam-V moiety that 
comprises the majority of the 1 scaffold and PMA binding within the C1B domain of PKC 
highlight three of the four hydrogen binding events shared between the two ligands (Wang, et al., 
1999). Flexibility of the indolactam-V moiety has been shown to have two major conformations: 
the cis-twist conformation and trans-sofa conformation (Figure 21). Evaluation of both 
conformations in the C1B domain binding site of PKC identified the cis-twist conformation of 
indolactacm-V as the dominant and most likely conformation for PKC activation (Wang, et al., 
1999). X-Ray crystal data for C1B binding to the indolactam-V moiety highlights hydrogen 
bonding between hydroxyl and carbonyl functional groups within the indolactam-V scaffold, and 
the Thr12 and Gly23 amido groups, respectively (Figure 22) (Wang, et al., 1999). Three chiral 
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carbon centers allow for eight distinct configurations, however only teleocidin A-1 (Takashima 
and Sakai, 1960), 2-oxo-3(R)-hydroxy-lyngbyatoxin A and  2-oxo-3(R)-hydroxy-13-N-desmethyl-
lyngbyatoxin A (Jiang, et al., 2014), and 9,12-epi lyngbyatoxin A (Awakawa, et al., 2014) have 
ever been observed in nature. Comparison of collected data to previously reported optical rotation 
and CD data confirm the conformation shown above (Figure 17). 
Compared to screening synthetic compound collections, screening of natural product 
extract libraries presents several difficulties in the search for novel compounds with biomedically 
relevant activities (Li and Vederas, 2009). Extracts are complex mixtures of compounds that often 
range in polarity and solubility. Active natural product compounds may be present in only minute 
quantities, and their activity may be overshadowed by other bioactive components or interfering 
nuisance compounds within the mixture. Crude extracts often contain pigmented compounds and 
may also contain autofluorescent metabolites. In addition, compounds may be less soluble when 
isolated and/or be unstable when not in the extract matrix. Furthermore, Zhao, et. al. (2016) 
demonstrated that compounds that affect lytic granule exocytosis would affect immune functions 
that involve lytic granule exocytosis, and on this basis might be expected to modulate antiviral and 
antitumor immunity. It is likely that many of the compounds identified as active in a screen based 
on lytic granule exocytosis, such as 1 or its derivatives would also affect the activity of other 
immune cells. As a result, this screening strategy can be applied to other cell types that respond to 
stimuli presented on a solid phase. The data presented by Zhao, et al. (2016) indicates that while 
some cells may only respond to soluble stimuli or may not produce optical scatter properties that 
allow their identification via flow cytometry, the assay is suitable for screening natural product 
extract libraries as part of an activity-guided fractionation scheme, and for repurposing previously 
identified bioactive molecules.  
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Figure 21. (A) Cis-twist and (B) trans-sofa conformations of indolactam-V during binding with 
PKC. The indolactam-V scaffold is responsible for extensive binding events in the C1B binding 
domain of PKC by teleocidin A-1 (1). The cis-twist conformation has been demonstrated as the 
dominant conformation for binding within the C1B domain of PKC (Wang, et al., 1999). 
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B. Bacterial Genome Investigation 
Our investigations of 1 as a promoter of CTL granule exocytosis led us to explore the 
bacteria responsible for secondary metabolite biosynthetic gene clusters and to evaluate its 
phylogeny. Preliminary BLAST comparisons of the 16S rRNA gene sequence identified our new 
isolate as a member of the genus Streptomyces. Using the ORFcor pipeline for phylogenetic 
analysis (Klassen and Currie, 2013) allowed us to identify the closest relative of our Streptomyces 
bacteria as a previously identified Streptomyces bacterium isolated from the deep ocean in the 
western Pacific Ocean near Japan known as Streptomyces sp. TP-A0873 (Figure 23 and Appendix 
B) (Komaki, et al., 2015). Both genomes, when analyzed using antiSMASH were shown to contain 
the biosynthetic gene cluster responsible for production of teleocidin B, a derivative of 1. The 
biosynthesis of teleocidin B includes the same three domains necessary for production of 1 with 
the addition of a fourth methyltransferase enzyme necessary for terpene cyclization known as tleD. 
Teleocidin B biosynthesis was derived from the genome of Streptomyces bacteria (Awakawa, et 
al., 2014). As mentioned earlier, 1 was later reisolated from the cyanobacterium Moorea producens 
(formerly Lyngbya majuscula) and named lyngbyatoxin A (Cardellina II, et. al. 1979). After 
rediscovery, the biosynthetic pathways associated with lyngbyatoxin A (teleocidin A-1, 1) were 
evaluated in cyanobacteria and the relevant PKS/NRPS enzymes were identified (Edwards and 
Gerwick, 2004). The antiSMASH results categorized biosynthetic gene clusters from our 
assembled genome with that of other genome sequences deposited for Streptomyces bacteria. 
Because all of the necessary gene sequences required for the biosynthesis of 1 are included in 
teleocidin B, it is likely that antiSMASH grouped the gene clusters identified for 1 with the closest 
partial biosynthetic gene cluster derived from other Streptomyces bacteria, namely teleocidin B. 
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Figure 22. X-Ray crystal data of (a) cis-twist conformation and (b) trans-sofa conformation of the 
indolactam-V during binding with PKC. The indolactam-V structure (green) highlights stronger 
hydrogen bonding between hydroxyl and carbonyl functional groups within the cis-twist 
indolactam-V scaffold, and the Thr12 and Gly23 amido groups, respectively residues among the 
C1B domain on PKC (CITE). The Leu21 amido group is also implicated in weaker hydrogen 
bonding events with the hydroxyl group and amido group within indolactam-V (Wang, et al., 1999). 
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Figure 23. Gene phylogeny tree of Streptomyces bacteria in NCBI library. This figure represents 
a portion of the phylogenetic tree created using fasttree (Price, 2009) (Price, 2010) from a set of 
conserved homologs using the ORFcor pipeline (Klassen and Currie, 2013) that were automated 
using MUSCLE (Edgar, 2004) and compares our draft genome with the entire NCBI library of 
Streptomyces bacteria (Jonathan Klassen, UConn Dept. of Molecular and Cellular Biology). 
Streptomyces sp. TP-A0873 was isolated from the deep Pacific off the Japanese coast, while 
Streptomyces sp. AVP053U2 was isolated from shallow surface water within Long Island Sound. 
The differences in genome sequence can be seen in the differences in biosynthetic gene clusters as 
evaluated by antiSMASH (Weber, et al., 2015). While both genomes have high overall sequence 
homology, fewer than half of the biosynthetic gene clusters identified share greater than 75% 
nucleotide sequence homology. The full phylogenetic tree is in Appendix B.  
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In addition to production of 1, other medically relevant biosynthetic gene clusters were 
identified within the genome of our bacteria. Streptomyces bacteria have historically been 
responsible for the production of interesting bioactive metabolites (Watve, et al., 2001). 
Investigation of identified biosynthetic gene clusters identified several biologically relevant 
secondary metabolite gene clusters including the known antibiotic albaflavenone (Table 6). 
Interestingly, investigation of the closest known relative of Streptomyces sp. AVP053U2, 
Streptomyces sp. TP-A0873, identified many of the same biosynthetic gene clusters present within 
the whole genome assembly. However, of the identified gene clusters shared between the two 
genomes, fewer than half of them shared greater than 75% sequence identity (Table 6). These 
differences in gene cluster sequence were likely the cause for the 0.3% difference in the overall 
phylogenetic separation, leading to a previously unidentified strain of Streptomyces. 
C. Localization of Bacteria in Tunicate Tissue 
The activity associated with granule exocytosis and PKC activation for 1 led us to question 
where sequestration of the bacteria took place within the tunicate in order to examine proximity of 
the bacteria to various tunicate metabolic pathways. Previous research has identified various 
bacterial associations for colonial tunicates within specific tissues (Riesenfeld, et al., 2008), but 
few studies have been performed investigating the location of bacterial symbionts amongst solitary 
tunicates such as Styela clava.  
However, the model solitary ascidian Ciona intestinalis has been demonstrated to harbor 
bacterial communities at various life stages within the gut region (Dishaw, et al., 2014) and within 
the tunic tissue (Blasiak, et al., 2014). Although, the authors expressed surprise at the dense 
population of intratunic bacteria amongst the Ciona specimens. Associations with symbiotic  
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Table 6. AntiSMASH analysis of the genome assembled for Streptomyces sp. AVP053U2 and Streptomyces sp. TP-A0873 (Weber, et al., 
2015). Relevant biosynthetic gene clusters were noted and the percent amino acid similarity for the aligned segment of each biosynthetic 
gene cluster is listed for each gene cluster. Cluster number denotes position in genome sequence. Percent similarity refers to similarity 
of examined genome sequences to database biosynthetic gene cluster data. Gene clusters without percent similarity rating were only 
identified to the type level. Genome for Streptomyces sp. AVP053U2 deposited in GenBank under the accession number: 
LMTQ00000000. Genome for Streptomyces sp. TP-A0873 accessed from GenBank using the accession number: BBNN00000000 
(Komaki, et al., 2015). 
           Streptomyces sp. AVP053U2 Streptomyces sp. TP-A0873 
Cluster 
Number 
Type Most Similar Known 
Cluster 
Percent 
Similarity 
 Cluster 
Number 
Type Most Similar Known 
Cluster 
Percent 
Similarity 
1 Terpene-T2pks Spore Pigment 75  1 Butyrolactone γ-Butyrolactone 100 
2 Indole-NRPS Teleocidin B 100  2 Transatpks Leinamycin 7 
3 Melanin - -  3 NRPS Akaeolide 12 
4 other Calcimycin 10  4 otherks-T2pks Cosmomycin D 62 
5 Siderophore Desferrioxamine B 66  5 Bacteriocin - - 
6 Terpene - -  6 Terpene - - 
7 Siderophore - -  7 Siderophore - - 
8 T1pks Borrelidin 46  8 Ectoine Ectoine 75 
9 Terpene Albaflavenone 100  9 NRPS-T1pks Antimycin  100 
10 Lantipeptide-NRPS Streptomycin 12  10 NRPS-T1pks Zorbamycin 4 
11 Butyrolactone-
T1pks 
Tetronasin 3  11 NRPS-Terpene Albaflavenone 100 
12 NRPS Zorbamycin 4  12 Lantipeptide-
NRPS 
Streptomycin 7 
13 NRPS-T1pks Antimycin 100  13 Indole-NRPS Teleocidin B 100 
14 Butyrolactone γ-Butyrolactone 100  14 other Kirromycin 27 
15 Nucleoside Toyocamycin 40  0 Melanin Melanin 40 
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16 Terpene Isorenieratene 100  16 other Chloramphenicol 23 
17 Ectoine Ectoine 100  17 Siderophore Desferrioxamine B 66 
18 NRPS Chalcomycin 4  18 Terpene - - 
19 T1pks - -  19 Terpene Hopene 76 
20 Terpene - -  20 Terpene Isorenieratene 100 
21 Bacteriocin Sisomicin 5  21 Nucleoside Toyocamycin 40 
22 NRPS-Ladderane-
Arylpolyene 
Skyllamycin 18  22 Terpene-T2pks Spore-Pigment 83 
23 Terpene Hopene 76  23 Arylpolyene Laspartomycin 9 
24 T1pks Candicidin 80  24 NRPS Candicidin 38 
25 NRPS Candicidin 38  25 T1pks Candicidin 85 
26 T3pks-NRPS UK-68,597 17  26 NRPS Chalcomycin 4 
27 NRPS-T1pks-
Transatpks 
Kirromycin 13  27 T1pks Nystatin 18 
28 NRPS-T1pks - -  28 Butyrolactone-
T1pks 
Tetronasin 3 
29 Amglyccycl-NRPS Arsenopolyketides 12  29 Terpene - - 
30 Terpene - -  30 NRPS Pristinamycin 5 
31 NRPS Enduracidin 12  31 T1pks - - 
32 Lantipeptide - -  32 Lantipeptide - - 
33 Lantipeptide - -  33 Ladderane-
Arylpolyene 
Colabomycin 9 
34 other Kirromycin 23  34 T1pks Apoptolidin 15 
35 NRPS - -  35 T1pks - - 
36 T1pks - -  36 T1pks - - 
37 T1pks - -  37 NRPS Tirandamycin 33 
38 NRPS - -  38 T1pks - - 
39 T1pks - -      
40 NRPS - -      
41 Lantipeptide - -      
42 NRPS - -      
43 NRPS WS9326 10      
44 NRPS - -      
45 T1pks - -      
46 NRPS - -      
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Prochloron cyanobacteria and host didemnid tunicates such as Lissoclinum patella have been 
extensively studied, yet fewer associations have been established for symbiotic heterotrophic 
bacteria and solitary tunicates (Lin, et al., 2016). In addition, bacterial associations with invasive 
tunicate species are often highly variable. It is thought that the associations of bacteria to host 
tunicates can aid in acclimation to new environments by establishing relationships with new 
locally-sourced bacteria (Erwin, et al., 2013). Because of the lack of bacterial genes amplified from 
tunicate tissue DNA extracts, the data presented here suggests that solitary tunicates such as Styela 
clava are less dependent on bacterial populations than other, more densely populated tunicate 
colonies, and thus harbor less bacteria within their tissue.   
Experiments were designed to investigate the presence of bacteria within various tissue 
DNA samples extracted from the tunicate specimens. Bacterial presence was verified in DNA 
samples extracted from the tunicate gut using PCR to amplify universal 16S rRNA regions of DNA. 
Surprisingly, however, the same region of DNA in samples taken from tunic tissue of Styela clava 
specimens did not indicate the presence of 16S rRNA. This could be a result of two scenarios: 1) 
bacterial DNA was not present intratunically or 2) it is possible that there was degradation of 
bacterial DNA as a result of the freeze-thaw cycles during DNA extraction.  
While it is often seen that undiscovered bacterial isolates can originate from tunic-derived 
bacterial cultures, it is not clear whether the cultures are present from intratunic bacteria or surface 
dwelling transient organisms. Interestingly, DNA from internal fluid contained regions of the 
Streptomyces 16S rRNA gene (Figure 19). This data implies that bacteria are not only housed 
within the tissue belonging to the tunicate, but are transported via the circulatory system, likely as 
a byproduct of the filter feeding mechanism. This was perhaps the most significant result, as it 
identified the presence of these biomedically relevant strains of bacteria within the environment 
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of the tunicate specimens. Moreover, upon examination of the DNA extracted from the surrounding 
sea water, the same universal bacterial housekeeping genes and specialized Streptomyces-linked 
genes were identified (Figure 19). As mentioned earlier, genomes identified from the 
Streptomyces-linked amplicons have demonstrated potential for production of antibiotic secondary 
metabolites. As a result, using the assembled genome sequence from Streptomyces sp. AVP053U2 
can help to identify other bacterial strains with the potential for medically relevant secondary 
metabolites in addition to our own new strain of Streptomyces.  
After identifying the presence of bacteria within the select groups of tunicate tissue DNA 
and surrounding sea water, specific teleocidin biosynthesis gene sequences were investigated in 
the same samples of DNA. The results indicated that although select regions of teleocidin 
biosynthesis genes were able to amplify in DNA extracted from isolated bacteria, the same regions 
did not amplify in DNA taken from the tunicate internal fluid or surrounding sea water (Figure 20). 
The inability to identify teleocidin biosynthesis genes may be attributed to two possible scenarios: 
1) sequences for teleocidin biosynthesis are diluted within the mixture of extracted DNA taken 
from tunicate tissues to amplify or 2) bacteria that are present within the tunicate gut, internal fluid, 
or surrounding sea water do not contain the biosynthetic gene clusters for teleocidin biosynthesis. 
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V. Conclusions 
This research was initiated to identify novel CTL augmenting metabolites extracted from 
tunicate-associated bacteria. The assay was designed for screening and identifying small molecule 
metabolites that enhance CTL granule exocytosis via PKC activation. From an extract of 
Streptomyces sp. AVP053U2 isolated from the tunicate Styela clava, we identified a potent PKC 
activator, teleocidin A-1 (1). Moreover, we were able to detect that activation of PKC by 1 was 
independent of intracellular calcium concentration.  
Following assay validation and chemical structure elucidation, the genome of the 
previously unidentified bacteria was sequenced and examined for the potential for production of 
other biologically relevant metabolites. This data allowed for exploration of other Streptomyces 
bacterial symbionts of Styela clava. When examined for secondary metabolite potential, other 
Streptomyces bacteria were shown to contain similar biosynthetic capabilities as the newly 
identified Streptomyces sp. AVP053U2. Further investigation using alternate techniques may allow 
for increased identification of associated bacteria in order to detect bacterial presence, and may 
localize the bacteria to other tissue segments more definitively. However, this data suggests that 
the majority of the bacteria that associate with Styela clava are localized to the internal segments 
of the body as opposed to the external tunic membranes. 
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VI. Appendix A 
 
Appendix A. Summary of PCR amplification experiments for 18S and 16S housekeeping genes. 
Lanes 2-5 represent amplification of S. clava 18S rDNA. Styela clava DNA used as positive control. 
1X TE Buffer used as negative vehicle control for tunic and gut tissue DNA samples. Lanes 6-11 
and 16-17 represent amplification of universal 16S rDNA. E. coli DNA used as positive control. 
1X TE Buffer used as a negative control for tunic and gut tissue DNA samples. 10mM Tris-HCl 
(Solution PW6 [MoBio Labs]) used as a negative control for both internal fluid and water sample 
DNA samples. Amplification experiments for internal fluid and for water sample DNA with 
universal 16S rDNA were performed separately and thus have two separate negative control runs. 
Samples that were indicated for universal bacteria 16S rDNA were also examined for 16S rDNA 
of AVP053U2-like bacteria. Lanes 12-15 and 18-19 represent amplification of selected region of 
Streptomyces sp. AVP053U2 16S rDNA. DNA from Streptomyces sp. AVP053U2 used as a 
positive control. 1X TE Buffer used as a negative control for gut tissue DNA and 10mM Tris-HCl 
(Solution PW6 [MoBio Labs]) used as a negative control for internal fluid and water sample DNA. 
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VII. Appendix B 
 
  
Appendix B. Gel electrophoresis of teleocidin biosynthesis gene segments in DNA from internal 
fluid and surface sea water. DNA from Streptomyces sp. AVP053U2 used as a positive control. 10 
mM Tris-HCl (Solution PW6 [MoBio Labs]) used as a negative vehicle control. Lanes 2-5 
represent amplification of tleA gene fragment. Lanes 6-9 represent amplifications of tleB gene 
fragments. Lanes 10-13 represent amplification of tleC gene fragment. Lanes 14-17 represent 
amplification of MbtH-like gene. The band in lane 4 represents primer dimerization during the 
PCR reaction. 
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